in

Exclusive: Dr. Peter Hotez’s Funding Linked to Controversial Chinese Military Scientists at Wuhan Lab

Funded by Dr. Fauci and Dr. Hotez’s R01AI098775 grant, Dr. Shibo Jiang and Dr. Lanying Du collaborated with scientists from the People’s Liberation Army and the Wuhan Institute of Virology.

Exclusive: Dr. Peter Hotez's Funding Linked to Controversial Chinese Military Scientists at Wuhan Lab
Exclusive: Dr. Peter Hotez's Funding Linked to Controversial Chinese Military Scientists at Wuhan Lab

In a groundbreaking revelation, it has come to light that Dr. Peter Hotez, an esteemed vaccine researcher, has been entangled in a web of funding, collaboration, and research with Chinese military scientists potentially involved in the development of COVID-19. The intricate tale weaves together key Chinese military virologists and culminates in the smoking gun evidence surrounding COVID-19’s notorious furin cleavage site.

At the center of this narrative lies Dr. Hotez, a distinguished professor at Baylor College of Medicine, who secured a substantial research grant (R01AI098775) from the National Institute of Allergy and Infectious Diseases (NIAID) led by Dr. Anthony Fauci. This grant, amounting to over $1 million per year, supports Dr. Hotez’s project titled “RBD Recombinant Protein-Based SARS Vaccine for Biodefense,” with Dr. Shibo Jiang listed as a Principal Investigator.

Dr. Shibo Jiang, a professor at Fudan University, boasts an impressive academic background. After completing his Master’s degree from the People’s Liberation Army’s Guangzhou First Military Medical University (广州第一军医大学) and his Medical Doctor degree from Xi’an Fourth Military Medical University (西安第四军医大学微), he pursued postdoctoral training at Rockefeller University in New York from 1987 to 1990.

What do you think?

Written by colinnew

Leave a Reply

Your email address will not be published. Required fields are marked *

FDA Approves 2 New Diabetes Drugs for Kids — Critic Says Clinical Trial Sample Was ‘Shockingly Low’

FDA Approves 2 New Diabetes Drugs for Kids — Critic Says Clinical Trial Sample Was ‘Shockingly Low’

The Untold Perspective About the #2 Killer in the World

Cancer Demystified: The Untold Perspective About the #2 Killer in the World